Biosimilars

Biopharmaceuticals, Biosimilars, General Waste, Pharmaceuticals

Price Controls Reduce Development and Access to Vital Cures

June 12, 2026 Eric Maus

As Americans prepare to celebrate the 250th anniversary of the nation’s founding, the festivities should include recognition of the United States as the global leader in biopharmaceutical development and innovation. However, America’s place atop the globe is being challenged by government intervention, specifically provisions in the Inflation Reduction Act (IRA) and Most Favored Nation (MFN) […]

Biopharmaceuticals, Biosimilars, Budget, General Waste, Healthcare, Obamacare, Pharmaceuticals

Salvage the Good from the Healthcare Debacle

August 1, 2006 Thomas Schatz

The healthcare reform juggernaut, arguably the most radical attempt to remake the economy and the nation’s healthcare infrastructure in history, was supposed to have flown through Congress before the August recess with nary a peep. Instead, as Americans have gotten wind of its alarming provisions and exorbitant costs, the plan appears to be fizzling fast in the summer heat.